Sign Up for FORCE
Newsletters
IMPROVING THE LIVES OF INDIVIDUALS AND FAMILIES FACING HEREDITARY CANCER.
September 15, 2022
National Hereditary Cancer Week 2022
National Hereditary Cancer Week (NHCW) and National Previvor Day are opportunities to shine the light on hereditary cancer, impart knowledge and save lives. Add your voice to our #1FORCECommunity, so we can make a difference together! This year,...
Featured XRAY
PARP inhibitor treatment for metastatic prostate cancer shows most benefit in men with inherited BRCA mutations
This study looked at the benefit of using the PARP inhibitor niraparib to treat metastatic castration-resistant prostate cancer (mCRPC). Participants included those with an inherited or tumor mutation in BRCA1 or BRCA2 or an inherited...
Featured Research
Survey about Endometrial Cancer Risk and Risk-Reducing Surgery for Women with a BRCA1/2 Mutation or Mutation in the Family
Researchers at the Mayo Clinic, McGill University and FORCE are conducting a survey of women with a BRCA1/2 mutation, or who come from a family with a known BRCA mutation but tested negative, or have...
Meet Our Community
Our impact is best shared through the stories of our growing community. Read about the survivors and previvors facing hereditary breast, colorectal, endometrial, ovarian, pancreatic and prostate cancers as a result of a BRCA, ATM, PALB2, CHEK2, PTEN or other inherited gene mutation and those with Lynch syndrome. We are comprised of many mutations and many cancers but we are one community!
